Van den Branden Astrid, Opdebeeck Britt, Adriaensen Saar, Evenepoel Pieter, Vanden Berghe Tom, Verhulst Anja
Cell Death Signaling Lab, Department of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp, Belgium.
Nephrology and Renal Transplantation Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
J Pathol. 2025 Feb;265(2):172-183. doi: 10.1002/path.6375. Epub 2024 Nov 29.
Arterial media calcification is a severe cardiovascular complication commonly manifesting in patients with chronic kidney disease (CKD). Patients with CKD frequently undergo intravenous iron therapy to address iron deficiency. Iron is suggested to be sequestered in vascular cells, potentially leading to oxidative (lipid) stress and cell death, which are recognized as key contributors to arterial calcification. The objective of this study was to investigate the effect of intravenous iron administration on CKD-induced arterial media calcification. Therefore, adenine-induced CKD rats were treated intravenously with iron and checked for arterial iron deposition and calcification, as well as for ferritin and lipid peroxidation markers. Additionally, arterial sections from patients with CKD who were dialysis dependent were analyzed for these parameters. This study showed that intravenous iron administration in CKD rats led to arterial iron deposition and a lipid peroxidation signature. CKD-induced arterial calcification was increased upon iron treatment and correlated with arterial iron accumulation and lipid peroxidation markers. Patients with CKD who were dialysis dependent showed arterial iron accumulation and elevated lipid peroxidation, but a direct correlation with arterial calcification was lacking. Taken together, iron treatment is suggested as a potential contributor to the calcification process, instead of being a predominant factor, thereby emphasizing the complexity of arterial calcification as a multifactorial disease. © 2024 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
动脉中层钙化是一种严重的心血管并发症,常见于慢性肾脏病(CKD)患者。CKD患者常接受静脉补铁治疗以纠正缺铁。有研究表明,铁会在血管细胞中蓄积,可能导致氧化(脂质)应激和细胞死亡,而这二者被认为是动脉钙化的关键因素。本研究的目的是探究静脉补铁对CKD诱导的动脉中层钙化的影响。因此,对腺嘌呤诱导的CKD大鼠进行静脉补铁治疗,并检测其动脉铁沉积、钙化情况,以及铁蛋白和脂质过氧化标志物。此外,还对依赖透析的CKD患者的动脉切片进行了这些参数的分析。本研究表明,对CKD大鼠静脉补铁会导致动脉铁沉积和脂质过氧化特征。铁治疗后,CKD诱导的动脉钙化增加,且与动脉铁蓄积和脂质过氧化标志物相关。依赖透析的CKD患者存在动脉铁蓄积和脂质过氧化升高的情况,但与动脉钙化缺乏直接相关性。综上所述,补铁治疗被认为是钙化过程的一个潜在促成因素,而非主要因素,这也凸显了动脉钙化作为一种多因素疾病的复杂性。© 2024作者。《病理学杂志》由约翰·威利父子有限公司代表大不列颠及爱尔兰病理学会出版。